Schizophrenia trials in Canada
40 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Where
- Calgary, Edmonton, Kingston, Montreal, Toronto
- Age
- 5 years to 17 years
- People
- 400 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT07424404 · EU 2025-524062-16-00 - No phaseTaking peopleMagnetic Seizure Therapy for Schizophrenia - Trial
- Where
- Toronto, Vancouver
- Age
- 18 years and over
- People
- 80
- Run by
- Centre for Addiction and Mental Health
See details and how to joinNCT06672588 - No phaseTaking peopleTheta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations
- Where
- Montreal
- Age
- 18 years and over
- People
- 12
- Run by
- Ciusss de L'Est de l'Île de Montréal
See details and how to joinNCT07902518 - No phaseTaking peopleSupporting Patients by Family Education in Psychotic Illness: A Prospective Cohort Study
- Where
- Edmonton
- Age
- 17 years to 27 years
- People
- 113
- Run by
- University of Alberta
See details and how to joinNCT05500001 - No phaseTaking peopleThe ATP Project (Antipsychotic-TEP-Psychosis)
- Where
- Sherbrooke
- Age
- 18 years to 35 years
- People
- 18
- Run by
- Université de Sherbrooke
See details and how to joinNCT06651112 - Phase 3Not yet taking people in CanadaStratification and Treatment in Early Psychosis Study - PROMOTE
- Where
- Montreal
- Age
- 12 years to 35 years
- People
- 586 worldwide
- Run by
- University of Oxford
See details and how to joinNCT07434973 - No phaseTaking peopleMultimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder
- Where
- Hamilton
- Age
- 18 years to 35 years
- People
- 10
- Run by
- McMaster University
See details and how to joinNCT07213492 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Where
- Brampton, Lévis, London, Toronto
- Age
- 55 years to 90 years
- People
- 300 worldwide
- Run by
- MapLight Therapeutics
See details and how to joinNCT06887192 · EU 2024-519820-26-00 - No phaseTaking peopleInvestigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use
- Where
- Montreal
- Age
- 16 years to 80 years
- People
- 134
- Run by
- Douglas Mental Health University Institute
See details and how to joinNCT05445180 - No phaseTaking peopleAccelerated Neuromodulation Therapy and Neurocomputational Biomarkers in Individuals at Clinical High Risk for Psychosis
- Where
- Verdun
- Age
- 18 years to 34 years
- People
- 40
- Run by
- Douglas Mental Health University Institute
See details and how to joinNCT07786714 - Phase 4Taking peopleSwitching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia
- Where
- Toronto
- Age
- 18 years and over
- People
- 30
- Run by
- Centre for Addiction and Mental Health
See details and how to joinNCT02639702 - No phaseTaking peopleAccelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia
- Where
- Montreal, Québec, Verdun
- Age
- 18 years to 65 years
- People
- 75
- Run by
- Douglas Mental Health University Institute
See details and how to joinNCT07428460 - No phaseEnrolling by invitationA Trial of Group Cognitive Behavioral Therapy for Psychosis (the Feeling Safe Programme)
- Where
- Ottawa
- Age
- 18 years and over
- People
- 50
- Run by
- The Royal Ottawa Mental Health Centre
See details and how to joinNCT07408934 - Phase 4Taking peopleBiomarkers to Enhance Early Schizophrenia Treatment
- Where
- Toronto
- Age
- 18 years to 35 years
- People
- 180 worldwide
- Run by
- Northwell Health
See details and how to joinNCT06969755 - Phase 3Taking peopleA Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Where
- Montreal, Toronto, Whitby
- Age
- 55 years to 90 years
- People
- 325 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06947941 - No phaseNot yet taking people in CanadaExploring the Genetics of Schizophrenia in Manitoba
- Where
- Winnipeg
- Age
- 18 years and over
- People
- 1,500
- Run by
- University of Manitoba
See details and how to joinNCT07656870 - No phaseTaking peopleRecovery With Exogenous Ketones and Antipsychotics
- Where
- Sherbrooke
- Age
- 18 years to 35 years
- People
- 15
- Run by
- Université de Sherbrooke
See details and how to joinNCT07122531 - No phaseTaking peopleREFLECT: A Novel Group-Based Compassion-Focussed Cognitive Behavioural Approach to Core Beliefs in Psychosis
- Where
- Scarborough Village
- Age
- 18 years and over
- People
- 38
- Run by
- University of Toronto
See details and how to joinNCT07569471 - No phaseTaking peopleHeat Stress in Individuals With Schizophrenia
- Where
- Ottawa
- Age
- 18 years to 85 years
- People
- 10
- Run by
- University of Ottawa
See details and how to joinNCT07383324 - No phaseTaking peopleExamining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis
- Where
- Ottawa
- Age
- 18 years to 60 years
- People
- 52
- Run by
- The Royal Ottawa Mental Health Centre
See details and how to joinNCT05973110 - Phase 4Taking people"Extended" (Alternate Day) Antipsychotic Dosing
- Where
- Toronto
- Age
- 18 years and over
- People
- 120
- Run by
- Centre for Addiction and Mental Health
See details and how to joinNCT04478838 - Phase 4Taking peopleCannabis Potency Effects on Brain White Matter in Early Phase Psychosis
- Where
- Halifax, St. John's
- Age
- 18 years to 25 years
- People
- 24
- Run by
- Nova Scotia Health Authority
See details and how to joinNCT07001878 - No phaseTaking peopleEffects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis
- Where
- Halifax, St. John's
- Age
- 16 years to 30 years
- People
- 50
- Run by
- Nova Scotia Health Authority
See details and how to joinNCT07056894 - No phaseTaking peopleEffects of NAC on Symptoms of CHR Patients
- Where
- Toronto
- Age
- 16 years to 35 years
- People
- 90
- Run by
- Centre for Addiction and Mental Health
See details and how to joinNCT05142735 - No phaseTaking peopleBrain Imaging of Cognition Inn Schizophrenia and Depression
- Where
- Ottawa
- Age
- 18 years to 60 years
- People
- 90
- Run by
- The Royal Ottawa Mental Health Centre
See details and how to joinNCT04159662